Return

Anti-Sm Ab (RDL)

Code:16005|CPT:86235|LOINC:11090-8

Synonyms
Специфичные АНАантитела к экстрагируемым ядерным (нуклеарным) антигенамантитела при аутоиммунных заболеваниях соединительной ткани.ANA-specific antibodiesAnti-extractable nuclear antibodiesAnti-Smith AbAnti-Smith antibodyAnti-Sm antibodyAntibodies in autoimmune connective tissue diseasesAntibodies to extractable nuclear antigensAntinuclear antibodies (ANA) comprehensive profileExtractable nuclear antigen (ENA) antibodies
IncludesAnti-Sm Ab (RDL)

Analysis details

Methodology

  • Enzyme immunoassay (EIA)

Expected Turnaround Time

1 day

Special Instructions

  • Avoid smoking for at least 30 minutes before the blood draw.

How to use

The Anti-Smith antibody (anti-Sm) test serves as a highly specific serologic marker for systemic lupus erythematosus, with limited sensitivity (approximately 20%–30% of SLE cases). In the setting of a positive antinuclear antibody (ANA) screen, anti-Sm results help substantiate a diagnosis of SLE and refine the differential among systemic autoimmune connective tissue diseases. Anti-Sm reactivity is uncommon outside SLE, with only occasional reports in monoclonal gammopathies and uveitis. The assay is commonly considered alongside extractable nuclear antigen (ENA) antibodies and other ANA-specific antibodies to contextualize serologic patterns.

Limitations

Anti-Sm (Smith) antibodies recognize antigens associated with U1, U2, and U4 small nuclear ribonucleoproteins. This specificity underpins their strong association with systemic lupus erythematosus and their infrequency in other systemic autoimmune diseases. Anti-Sm status contributes to SLE classification frameworks. Antibody concentrations do not correlate with systemic lupus erythematosus disease activity and are not suitable for monitoring disease course. Accordingly, anti-Sm testing is used for diagnostic classification and differential diagnosis rather than for serial disease tracking.

Reference interval
MinMax
030
IndicationsPositive ANA by HEp-2 indirect immunofluorescence or an equivalent screening method., Clinical picture consistent with a systemic autoimmune connective tissue disorder (for example, photosensitivity, inflammatory arthritis, Raynaud phenomenon, leukopenia, autoimmune hemolytic anemia, persistent fever, weight loss, or myalgia)., Clarifying the differential diagnosis when systemic lupus erythematosus or overlap syndromes are suspected., Follow-up serologic assessment in patients with known or suspected systemic connective tissue disease.

Specimen Requirements

SpecimenSerum
ContainerGold/Tiger Top (SST, Gel Separator)
Volume1 mL (min 0.3 mL)
Storage InstructionsRoom temperature, Refrigerated, Frozen

References

Fischbach F.T., Dunning M.B. A Manual of Laboratory and Diagnostic Tests. 8th ed. Lippincott Williams & Wilkins; 2008:1344.

Wilson D. McGraw-Hill Manual of Laboratory and Diagnostic Tests. 1st ed. McGraw-Hill; 2007:666.

Sabatine M. Pocket Medicine. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.